Sinclair Pharma plc
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them (in accordance with the Market Abuse Regulations)
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
a. |
Name |
Alan Olby |
||||
2. |
Reason for the notification |
|||||
a. |
Position/status |
Chief Financial Officer |
||||
b. |
Initial notification /Amendment |
Initial Announcement |
||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a. |
Name |
Sinclair Pharma plc |
||||
b. |
LEI |
|
||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a. |
Description of the Financial instrument, type of instrument Identification code |
Ordinary Shares of 1 pence each in Sinclair Pharma plc
GB0033856740 |
||||
b. |
Nature of the transaction |
Exercise of Replacement Options
|
||||
c. |
Price(s) and volume(s) |
|
||||
d. |
Aggregated information · Aggregated volume · Price
|
N/A
|
||||
e. |
Date of the transaction |
2016-11-14 |
||||
f. |
Place of the transaction |
London Stock Exchange
|
You are here: news > regulatory news